CN117223710A - Sterilizing composition containing menthone - Google Patents
Sterilizing composition containing menthone Download PDFInfo
- Publication number
- CN117223710A CN117223710A CN202311019812.6A CN202311019812A CN117223710A CN 117223710 A CN117223710 A CN 117223710A CN 202311019812 A CN202311019812 A CN 202311019812A CN 117223710 A CN117223710 A CN 117223710A
- Authority
- CN
- China
- Prior art keywords
- menthone
- magnolol
- carvacrol
- oregano oil
- fusarium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 title claims abstract description 243
- 229930007503 menthone Natural products 0.000 title claims abstract description 243
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 title claims abstract description 229
- 239000000203 mixture Substances 0.000 title claims abstract description 21
- 230000001954 sterilising effect Effects 0.000 title claims abstract description 6
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 claims abstract description 167
- 235000007746 carvacrol Nutrition 0.000 claims abstract description 84
- HHTWOMMSBMNRKP-UHFFFAOYSA-N carvacrol Natural products CC(=C)C1=CC=C(C)C(O)=C1 HHTWOMMSBMNRKP-UHFFFAOYSA-N 0.000 claims abstract description 84
- WYXXLXHHWYNKJF-UHFFFAOYSA-N isocarvacrol Natural products CC(C)C1=CC=C(O)C(C)=C1 WYXXLXHHWYNKJF-UHFFFAOYSA-N 0.000 claims abstract description 84
- RECUKUPTGUEGMW-UHFFFAOYSA-N carvacrol Chemical compound CC(C)C1=CC=C(C)C(O)=C1 RECUKUPTGUEGMW-UHFFFAOYSA-N 0.000 claims abstract description 79
- 239000010661 oregano oil Substances 0.000 claims abstract description 67
- 229940111617 oregano oil Drugs 0.000 claims abstract description 67
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 40
- 235000017060 Arachis glabrata Nutrition 0.000 claims abstract description 21
- 244000105624 Arachis hypogaea Species 0.000 claims abstract description 21
- 235000010777 Arachis hypogaea Nutrition 0.000 claims abstract description 21
- 235000018262 Arachis monticola Nutrition 0.000 claims abstract description 21
- 241000209140 Triticum Species 0.000 claims abstract description 21
- 235000021307 Triticum Nutrition 0.000 claims abstract description 21
- 235000020232 peanut Nutrition 0.000 claims abstract description 21
- 206010039509 Scab Diseases 0.000 claims abstract description 16
- 240000008042 Zea mays Species 0.000 claims abstract description 13
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 claims abstract description 13
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims abstract description 13
- 235000005822 corn Nutrition 0.000 claims abstract description 13
- 208000031888 Mycoses Diseases 0.000 claims description 8
- 230000002195 synergetic effect Effects 0.000 abstract description 28
- 241000196324 Embryophyta Species 0.000 abstract description 21
- 238000013329 compounding Methods 0.000 abstract description 17
- 201000010099 disease Diseases 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 8
- 230000002265 prevention Effects 0.000 abstract description 5
- 241001529744 Origanum Species 0.000 abstract description 4
- 235000011203 Origanum Nutrition 0.000 abstract description 4
- 239000003921 oil Substances 0.000 abstract description 4
- 239000000575 pesticide Substances 0.000 abstract description 4
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 244000000004 fungal plant pathogen Species 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 description 40
- 239000003814 drug Substances 0.000 description 22
- 241001451172 Fusarium pseudograminearum Species 0.000 description 18
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 15
- 241000223218 Fusarium Species 0.000 description 15
- 230000004071 biological effect Effects 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 13
- 241000879295 Fusarium equiseti Species 0.000 description 10
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 10
- 241000223221 Fusarium oxysporum Species 0.000 description 9
- 241000813090 Rhizoctonia solani Species 0.000 description 9
- 239000003899 bactericide agent Substances 0.000 description 8
- 238000011160 research Methods 0.000 description 8
- 241001530056 Athelia rolfsii Species 0.000 description 7
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 5
- 239000005770 Eugenol Substances 0.000 description 5
- 241000221779 Fusarium sambucinum Species 0.000 description 5
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- 229960002217 eugenol Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 231100000419 toxicity Toxicity 0.000 description 5
- 230000001988 toxicity Effects 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- HPUXDMUGCAWDFW-UHFFFAOYSA-N Osthole Natural products COc1ccc2CCC(=O)Oc2c1C=CC(=O)C HPUXDMUGCAWDFW-UHFFFAOYSA-N 0.000 description 4
- 230000003385 bacteriostatic effect Effects 0.000 description 4
- 230000000536 complexating effect Effects 0.000 description 4
- MBRLOUHOWLUMFF-UHFFFAOYSA-N osthole Chemical compound C1=CC(=O)OC2=C(CC=C(C)C)C(OC)=CC=C21 MBRLOUHOWLUMFF-UHFFFAOYSA-N 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 3
- 230000001018 virulence Effects 0.000 description 3
- OICGFSUWXCJLCO-UHFFFAOYSA-N 1-ethylsulfonylsulfanylethane Chemical compound CCSS(=O)(=O)CC OICGFSUWXCJLCO-UHFFFAOYSA-N 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 230000006806 disease prevention Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- PVTHJAPFENJVNC-MHRBZPPQSA-N kasugamycin Chemical compound N[C@H]1C[C@H](NC(=N)C(O)=O)[C@@H](C)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O)[C@@H]1O PVTHJAPFENJVNC-MHRBZPPQSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000010413 mother solution Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- AMNAZJFEONUVTD-KEWDHRJRSA-N (2s,3s,4s,5r,6r)-6-(4-amino-2-oxopyrimidin-1-yl)-4,5-dihydroxy-3-[[(2s)-3-hydroxy-2-[[2-(methylamino)acetyl]amino]propanoyl]amino]oxane-2-carboxamide Chemical compound O1[C@H](C(N)=O)[C@@H](NC(=O)[C@H](CO)NC(=O)CNC)[C@H](O)[C@@H](O)[C@@H]1N1C(=O)N=C(N)C=C1 AMNAZJFEONUVTD-KEWDHRJRSA-N 0.000 description 1
- 240000004510 Agastache rugosa Species 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 241000050051 Chelone glabra Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 101100136092 Drosophila melanogaster peng gene Proteins 0.000 description 1
- 241000221785 Erysiphales Species 0.000 description 1
- 235000016623 Fragaria vesca Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 1
- 241001149959 Fusarium sp. Species 0.000 description 1
- FEACDOXQOYCHKU-UHFFFAOYSA-N Gougerotin Natural products CNCC(=O)NC1=NC(=O)N(C=C1)C2OC(C(O)C(NC(=O)C(N)CO)C2O)C(=O)N FEACDOXQOYCHKU-UHFFFAOYSA-N 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- QNVSXXGDAPORNA-UHFFFAOYSA-N Resveratrol Natural products OC1=CC=CC(C=CC=2C=C(O)C(O)=CC=2)=C1 QNVSXXGDAPORNA-UHFFFAOYSA-N 0.000 description 1
- 241000951473 Schizonepeta Species 0.000 description 1
- 240000003768 Solanum lycopersicum Species 0.000 description 1
- LUKBXSAWLPMMSZ-OWOJBTEDSA-N Trans-resveratrol Chemical compound C1=CC(O)=CC=C1\C=C\C1=CC(O)=CC(O)=C1 LUKBXSAWLPMMSZ-OWOJBTEDSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- VMFXMTJCTSYHCF-HHQUSWFZSA-N [(2r,3r,4s,5r)-5-(hexylamino)-4-hydroxy-2-(hydroxymethyl)-6-[(7-hydroxy-4-oxo-1,3a,5,6,7,7a-hexahydroimidazo[4,5-c]pyridin-2-yl)amino]oxan-3-yl] carbamate Chemical compound CCCCCCN[C@@H]1[C@H](O)[C@@H](OC(N)=O)[C@@H](CO)OC1\N=C\1NC(C(=O)NCC2O)C2N/1 VMFXMTJCTSYHCF-HHQUSWFZSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000012271 agricultural production Methods 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000003589 local anesthetic agent Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- -1 monoterpene compounds Chemical class 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000003223 protective agent Substances 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 229940016667 resveratrol Drugs 0.000 description 1
- 235000021283 resveratrol Nutrition 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 230000002110 toxicologic effect Effects 0.000 description 1
- 231100000027 toxicology Toxicity 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
The invention belongs to the technical field of pesticides, and particularly relates to a sterilization composition containing menthone. A bactericidal composition containing menthone is prepared by compounding magnolol, carvacrol or oregano oil and menthone as effective components. According to the invention, magnolol, carvacrol or origanum oil and menthone are compounded according to a certain mass, a synergistic effect is shown on various plant pathogenic fungi, the control effect on plant diseases can be improved, data support is provided for effective prevention and control of wheat stem rot, wheat scab, peanut root rot, peanut southern blight and corn scab, and the invention has important significance on high quality and high yield of crops such as wheat, peanut and corn.
Description
Technical Field
The invention belongs to the technical field of pesticides, and particularly relates to a sterilization composition containing menthone.
Background
The occurrence of diseases causes great threat to agricultural production, and the use of chemical pesticides plays an important role in preventing, controlling crop diseases, ensuring stable yield and high yield of agricultural and forestry crops and the like. However, long-term application of chemical pesticides is easy to cause poisoning of people and livestock, high residue, environmental pollution and other consequences, and hidden danger is brought to ecological environment and human health.
The plant source bactericide is one medicine prepared with some parts of plant with bactericidal and bacteriostatic activity and extracted effective components and separated and purified monomer matter and through processing. The botanical fungicide gradually becomes a hot spot for controlling plant diseases due to the unique advantages of high efficiency, low toxicity, low residue, high selectivity, small influence on environment and the like. At present, scholars at home and abroad have conducted a great deal of research on the aspect of controlling fungal diseases by using a plant source bactericide, and find a plurality of plant resources with bactericidal action, which provides important basis for disease control research by using the plant source bactericide.
Currently, a plurality of plant source bactericides including ethylicin, kasugamycin, eugenol, carvacrol, osthole and the like exist in the market, are popularized and applied to the prevention and treatment of various crop diseases, and achieve remarkable prevention and treatment effects. For example Wang Zhifeng, eugenol has a strong antifungal effect and has a control effect of 78% on tomato late blight; peng Zhiguo and the like report that the control effect of the 1% osthole on powdery mildew of cucumber in a greenhouse reaches 79.33%; sun Xuemei the control effect of the ethylicin, kasugamycin, ningnanmycin and Zhongshengmycin on strawberry leaf spot disease can reach more than 80% through root dipping treatment; meanwhile, the latest researches of Zheng Anke and the like show that 9 plant source bactericides such as eugenol, allicin and osthole to be tested have an inhibiting effect on sunflower rust bacteria, 0.3% eugenol has the strongest toxicity, and the inhibiting effect is as high as more than 85%, and further show that the plant source bactericides have stronger potential for preventing and controlling plant diseases.
Menthone belongs to monoterpene compounds, widely exists in volatile oils of various plants such as peppermint, schizonepeta, baical skullcap root, wrinkled giant hyssop and the like, and researches show that the menthone has the effects of resisting viruses, resisting inflammation, promoting bile flow, promoting permeation and the like. At present, menthone and derivatives thereof are relatively widely applied in medicine and mainly used as local anesthetic, protective agent and the like, but are reported in the research process of plant diseases.
The prior researches of the inventor find that the menthone has better antibacterial effects on wheat stem basal rot, wheat scab, peanut root rot, peanut southern blight, corn scab and the like, and has better disease prevention and control potential. In order to further use menthone to develop plant disease prevention and control, the inventor develops compound researches on menthone, magnolol, carvacrol, oregano oil, osthole, eugenol, resveratrol, garlicin and other plant source bactericides, and partial compound combinations of the plant source bactericides show a strong synergistic effect, and the research results provide data support for effective prevention and control of wheat stem rot, wheat scab, peanut root rot, peanut southern blight and corn scab and have important significance for high quality and high yield of crops such as wheat, peanut and corn.
The information disclosed in this background section is only for enhancement of understanding of the general background of the invention and should not be taken as an acknowledgement or any form of suggestion that this information forms the prior art already known to a person of ordinary skill in the art.
Disclosure of Invention
The invention aims to provide a menthone-containing bactericidal composition which can effectively inhibit the growth of pathogenic bacteria such as wheat stem rot, wheat scab, peanut root rot, peanut southern blight, corn scab and the like, effectively prevent and control various plant fungal diseases, and has important significance for the high quality and high yield of crops such as wheat, peanut, corn and the like.
In order to achieve the above purpose, the present invention provides the following technical solutions:
a bactericidal composition containing menthone is prepared by compounding magnolol, carvacrol or oregano oil and menthone as effective components.
Preferably, the mass ratio of magnolol to menthone is 1-9:9-1.
Preferably, the mass ratio of carvacrol to menthone is 1-9:9-1.
Preferably, the mass ratio of the oregano oil to the menthone is 1-9:9-1.
The invention also provides application of the menthone-containing bactericidal composition in preventing and controlling fungal diseases of crops.
Preferably, the crop fungal diseases include wheat stem rot, wheat scab, peanut root rot, peanut southern blight and corn scab.
Compared with the prior art, the invention has the following beneficial effects:
according to the invention, magnolol, carvacrol or origanum oil and menthone are compounded according to a certain mass, a synergistic effect is shown on pathogenic bacteria of various plant fungal diseases, the control effect on plant diseases can be improved, data support is provided for effective control of wheat stem rot, wheat scab, peanut root rot, peanut southern blight and corn scab, and the invention has important significance on high quality and high yield of crops such as wheat, peanut and corn.
Detailed Description
The following is a clear and complete description of the technical solutions of the present patent.
Examples
1. Test strain
TABLE 1 test strains
2. Test agent
98% magnolol (Shanghai Yuan Ye Biotechnology Co., ltd.), 92.5% carvacrol (Shanghai Yuan Ye Biotechnology Co., ltd.), 98% Oregano oil (Hubei Heng Jing Rui chemical Co., ltd.), 99% menthone (Wuhan Rong and Can Biotechnology Co., ltd.).
After the test agent is dissolved, diluting the test agent into a single-agent mother solution by using 0.1% Tween-80 aqueous solution, setting a plurality of groups of proportions, and setting 5 mass concentration gradients of each single-agent mother solution and each proportion mixture according to an equal proportion method.
3. Test method
Adding 9mL of pre-melted PDA culture medium into a sterile conical flask, sequentially quantitatively sucking 1mL of liquid medicine from low concentration to high concentration, respectively adding into the conical flask, fully shaking uniformly, pouring into 1 culture dishes with the diameter of 9cm, preparing medicine-containing flat plates with corresponding concentrations, simultaneously setting treatment without medicines as blank control, and treating 10 flat plates with each liquid medicine with the mass concentration. Cutting bacterial cake at the colony edge of the tested bacterial strain by using a puncher with the diameter of 5mm, inoculating the bacterial cake to the centers of a medicine-containing flat plate and a blank control flat plate, covering a dish cover, and placing the dish cover in a constant temperature oven at 25 ℃ for cultivation. When the diameter of the blank control colony grows to about 2/3 of the diameter of the culture dish, measuring the colony diameter by a crisscross method, and calculating the inhibition rate of different treatments on hypha growth.
4. Data analysis
Data statistics analysis is carried out by adopting DPS software to obtain a virulence regression equation and virulence EC of the medicament on target bacteria 50 Values and co-toxicity coefficients (CTCs) were calculated according to the grand cloud Pei method.
In the above formula: the toxicity index measured by the ATI-mixed agent; EC of S-standard agent 50 The unit is mg/L; EC of M-mixture 50 The unit is mg/L.
TTI＝TI A ×P A +TI B ×P B
In the above formula: theoretical toxicological index of TTI-blends; TI (TI) A -a toxicity index of the agent; p (P) A -a percentage of agent in the mix in percent (%); TI (TI) B -a toxicity index of the B agent; p (P) B The percentage of agent B in the mixture is expressed as a percentage (%).
In the above formula: CTC-co-toxicity coefficient; the ATI-mixed agent actually measures the toxicity index; TTI-blend theoretical virulence index.
5. Measurement results
The synergy of the agents was evaluated based on the calculated co-toxicity coefficient (CTC), CTC.ltoreq.80 being antagonism, CTC.ltoreq.120 being additive, CTC.ltoreq.120 being synergy, the results are shown in tables 2-25.
TABLE 2 determination of indoor biological Activity of a sclerotium rolfsii by combination of magnolol and menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Magnolol | 16.1248 | 100.0000 | -- | -- |
| Menthone | 59.6386 | 27.0375 | -- | -- |
| Magnolol 9: menthone 1 | 4.8374 | 333.3361 | 92.7038 | 359.5713 |
| Magnolol 8: menthone 2 | 2.6875 | 599.9926 | 85.4075 | 702.5057 |
| Magnolol 7: menthone 3 | 2.5460 | 633.3386 | 78.1113 | 810.8160 |
| Magnolol 6: menthone 4 | 5.3749 | 300.0019 | 70.8150 | 423.6416 |
| Magnolol 5: menthone 5 | 0.5691 | 2833.3860 | 63.5188 | 4460.7073 |
| Magnolol 4: menthone 6 | 8.0624 | 200.0000 | 56.2225 | 355.7294 |
| Magnolol 3: menthone 7 | 1.1799 | 1366.6243 | 48.9263 | 2793.2324 |
| Magnolol 2: menthone 8 | 3.0234 | 533.3333 | 41.6300 | 1281.1268 |
| Magnolol 1: menthone 9 | 4.0312 | 400.0000 | 34.3338 | 1165.0337 |
From table 2, it can be seen that the aligned micronucleus bacteria show excellent antibacterial activity after the magnolol and the menthone are compounded. The co-toxicity coefficient of all the tested compound combination aligned sclerotium rolfsii is more than 120, and the synergistic effect is shown. Especially when the compounding ratio of magnolol and menthone is 5:5, the co-toxicity coefficient reaches 4460.7073, and the synergy is remarkable.
TABLE 3 determination of indoor biological Activity of Fusarium pseudograminearum by complexing magnolol with menthone
From table 3, it can be seen that magnolol and menthone show excellent antibacterial activity against fusarium pseudograminearum after being compounded. When the compounding ratio of magnolol to menthone is 7:3 and 6:4, exhibit antagonism; when the compounding ratio of magnolol to menthone is 9: 1. 8:2 and 5: at 5, the addition is shown; the co-toxicity coefficient of the other compound combinations on the fusarium pseudograminearum is more than 120, and the synergistic effect is shown.
Table 4 determination of indoor biological Activity of rhizoctonia solani compounded with magnolol and menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Magnolol | 4.7179 | 100.0000 | -- | -- |
| Menthone | 30.6867 | 15.3744 | -- | -- |
| Magnolol 9: menthone 1 | 3.7247 | 126.6652 | 91.5374 | 138.3753 |
| Magnolol 8: menthone 2 | 4.0439 | 116.6671 | 83.0749 | 140.4360 |
| Magnolol 7: menthone 3 | 3.3700 | 139.9970 | 74.6123 | 187.6326 |
| Magnolol 6: menthone 4 | 2.1944 | 214.9973 | 66.1498 | 325.0159 |
| Magnolol 5: menthone 5 | 2.1284 | 221.6642 | 57.6872 | 384.2519 |
| Magnolol 4: menthone 6 | 9.4359 | 49.9995 | 49.2246 | 101.5741 |
| Magnolol 3: menthone 7 | 14.1538 | 33.3331 | 40.7621 | 81.7748 |
| Magnolol 2: menthone 8 | 28.3076 | 16.6665 | 32.2995 | 51.6000 |
| Magnolol 1: menthone 9 | 47.1793 | 9.9999 | 23.8370 | 41.9514 |
From table 4, it can be seen that the magnolol and menthone after being compounded show excellent antibacterial activity against rhizoctonia solani. When the compounding ratio of magnolol to menthone is 2:8 and 1: at 9, it appears antagonistic; when the compounding ratio of magnolol to menthone is 4:6 and 3: at 7, the addition is performed; the co-toxicity coefficient of the other compound combinations to the rhizoctonia solani is more than 120, and the synergistic effect is shown.
TABLE 5 determination of indoor biological Activity of Fusarium pseudograminearum by complexing magnolol with menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Magnolol | 3.0035 | 100.0000 | -- | -- |
| Menthone | 58.2502 | 5.1562 | -- | -- |
| Magnolol 9: menthone 1 | 1.3564 | 221.4317 | 90.5156 | 244.6337 |
| Magnolol 8: menthone 2 | 1.2742 | 235.7165 | 81.0312 | 290.8959 |
| Magnolol 7: menthone 3 | 0.8761 | 342.8262 | 71.5469 | 479.1631 |
| Magnolol 6: menthone 4 | 0.9826 | 305.6686 | 62.0625 | 492.5176 |
| Magnolol 5: menthone 5 | 0.8410 | 357.1344 | 52.5781 | 679.2454 |
| Magnolol 4: menthone 6 | 0.7509 | 399.9867 | 43.0937 | 928.1785 |
| Magnolol 3: menthone 7 | 0.7645 | 392.8712 | 33.6093 | 1168.9343 |
| Magnolol 2: menthone 8 | 0.6893 | 435.7319 | 24.1250 | 1806.1453 |
| Magnolol 1: menthone 9 | 0.5760 | 521.4410 | 14.6406 | 3561.6130 |
From table 5, it can be seen that magnolol and menthone show excellent antibacterial activity against fusarium pseudograminearum after being compounded. The co-toxicity coefficient of all tested compound combinations to the fusarium pseudograminearum is more than 120, and the synergistic effect is shown. Especially when the compounding ratio of magnolol and menthone is 1:9, the co-toxicity coefficient reaches 3561.6130, and the synergy is remarkable.
Table 6 determination of indoor biological Activity of Fusarium roseum by combination of magnolol and menthone
From table 6, it can be seen that magnolol and menthone show excellent antibacterial activity against fusarium erythropolis after being compounded. When the compounding ratio of magnolol to menthone is 1:9, the co-toxicity coefficient of the compound combination on Fusarium rubrum is larger than 120, and the synergistic effect is shown.
Table 7 determination of indoor biological Activity of Fusarium equisetum by complexing magnolol with menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Magnolol | 4.1399 | 100.0000 | -- | -- |
| Menthone | 145.5956 | 2.8434 | -- | -- |
| Magnolol 9: menthone 1 | 4.5681 | 90.6263 | 90.2843 | 100.3788 |
| Magnolol 8: menthone 2 | 8.2797 | 50.0006 | 80.5687 | 62.0596 |
| Magnolol 7: menthone 3 | 9.4626 | 43.7501 | 70.8530 | 61.7477 |
| Magnolol 6: menthone 4 | 6.9724 | 59.3755 | 61.1374 | 97.1182 |
| Magnolol 5: menthone 5 | 8.1354 | 50.8875 | 51.4217 | 98.9611 |
| Magnolol 4: menthone 6 | 13.2476 | 31.2502 | 41.7061 | 74.9296 |
| Magnolol 3: menthone 7 | 8.6565 | 47.8242 | 31.9904 | 149.4954 |
| Magnolol 2: menthone 8 | 12.4825 | 33.1656 | 22.2747 | 148.8935 |
| Magnolol 1: menthone 9 | 10.1905 | 40.6251 | 12.5591 | 323.4718 |
From Table 7, it is clear that magnolol and menthone show excellent antibacterial activity against Fusarium equisetum after being compounded. When the compounding ratio of magnolol to menthone is 3: 7. 2:8 and 1:9, the co-toxicity coefficient of the compound combination on the fusarium equiseti is more than 120, and the synergistic effect is shown.
Table 8 determination of indoor biological Activity of Fusarium on Compound pair of magnolol and menthone
From table 8, it can be seen that the magnolol and menthone after being compounded show excellent antibacterial activity on fusarium. When the compounding ratio of magnolol to menthone is 9: 1. 8:2 and 7:3, the compound combination shows additive effect on fusarium; the other compound combinations show synergistic effect on Fusarium layering.
Table 9 determination of indoor biological Activity of Fusarium oxysporum compounded with magnolol and menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Magnolol | 6.2780 | 100.0000 | -- | -- |
| Menthone | 144.7977 | 4.3357 | -- | -- |
| Magnolol 9: menthone 1 | 5.4933 | 114.2847 | 90.4336 | 126.3742 |
| Magnolol 8: menthone 2 | 6.2321 | 100.7365 | 80.8671 | 124.5704 |
| Magnolol 7: menthone 3 | 4.9389 | 127.1133 | 71.3007 | 178.2778 |
| Magnolol 6: menthone 4 | 6.5912 | 95.2482 | 61.7343 | 154.2874 |
| Magnolol 5: menthone 5 | 7.9902 | 78.5712 | 52.1679 | 150.6124 |
| Magnolol 4: menthone 6 | 8.2399 | 76.1902 | 42.6014 | 178.8444 |
| Magnolol 3: menthone 7 | 6.9389 | 90.4754 | 33.0350 | 273.8776 |
| Magnolol 2: menthone 8 | 5.8595 | 107.1422 | 23.4686 | 456.5352 |
| Magnolol 1: menthone 9 | 7.8813 | 79.6569 | 13.9021 | 572.9833 |
From Table 9, it is clear that magnolol and menthone show excellent antibacterial activity against Fusarium oxysporum after being compounded. The co-toxicity coefficient of all tested compound combinations to fusarium oxysporum is more than 120, and the synergistic effect is shown. The compounding ratio of magnolol and menthone is 1:9, the co-toxicity coefficient reaches 572.9833, and the synergy is remarkable.
Table 10 determination of indoor bioactivity of carvacrol and menthone compounded with sclerotium rolfsii
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Carvacrol | 48.2768 | 100.0000 | -- | -- |
| Menthone | 59.6386 | 80.9489 | -- | -- |
| Carvacrol 9: menthone 1 | 59.1144 | 81.6667 | 98.0949 | 83.2528 |
| Carvacrol 8: menthone 2 | 53.6408 | 90.0001 | 96.1898 | 93.5652 |
| Carvacrol 7: menthone 3 | 27.8520 | 173.3333 | 94.2847 | 183.8404 |
| Carvacrol 6: menthone 4 | 28.9661 | 166.6666 | 92.3796 | 180.4150 |
| Carvacrol 5: menthone 5 | 29.9661 | 161.1047 | 90.4745 | 178.0665 |
| Carvacrol 4: menthone 6 | 68.9668 | 70.0001 | 88.5693 | 79.0342 |
| Carvacrol 3: menthone 7 | 181.0379 | 26.6667 | 86.6642 | 30.7701 |
| Carvacrol 2: menthone 8 | 1448.3028 | 3.3333 | 84.7591 | 3.9327 |
| Carvacrol 1: menthone 9 | 111.4079 | 43.3334 | 82.8540 | 52.3009 |
From table 10, it can be seen that the aligned micronucleus exhibits excellent antibacterial activity after carvacrol and menthone are compounded. When the compound proportion of carvacrol and menthone is 7: 3. 6:4 and 5: and 5, the co-toxicity coefficients of the compound combination and the aligned sclerotium rolfsii are all larger than 120, so that the synergistic effect is shown.
Table 11 determination of indoor bioactivity of carvacrol and menthone compounded Fusarium pseudograminearum
From table 11, it can be seen that carvacrol and menthone after being compounded show excellent antibacterial activity against fusarium pseudograminearum. When the compound proportion of carvacrol and menthone is 9-5:1-5, which represents addition; the co-toxicity coefficient of the other compound combinations on the fusarium pseudograminearum is more than 120, and the synergistic effect is shown.
Table 12 determination of indoor bioactivity of carvacrol and menthone compounded against rhizoctonia solani
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Carvacrol | 11.0604 | 100.0000 | -- | -- |
| Menthone | 30.6867 | 36.0430 | -- | -- |
| Carvacrol 9: menthone 1 | 10.0421 | 110.1403 | 93.6043 | 117.6659 |
| Carvacrol 8: menthone 2 | 10.9836 | 100.6992 | 87.2086 | 115.4694 |
| Carvacrol 7: menthone 3 | 10.7321 | 103.0590 | 80.8129 | 127.5280 |
| Carvacrol 6: menthone 4 | 14.9564 | 73.9510 | 74.4172 | 99.3735 |
| Carvacrol 5: menthone 5 | 25.1054 | 44.0559 | 68.0215 | 64.7676 |
| Carvacrol 4: menthone 6 | 35.1475 | 31.4685 | 61.6258 | 51.0639 |
| Carvacrol 3: menthone 7 | 22.6758 | 48.7762 | 55.2301 | 88.3146 |
| Carvacrol 2: menthone 8 | 37.4340 | 29.5464 | 48.8344 | 60.5033 |
| Carvacrol 1: menthone 9 | 35.1475 | 31.4685 | 42.4387 | 74.1506 |
From table 12, it can be seen that carvacrol and menthone, after being compounded, show excellent antibacterial activity against rhizoctonia solani. When the compound proportion of carvacrol and menthone is 7: and 3, the co-toxicity coefficient of the compound combination to the rhizoctonia solani is more than 120, so that the synergistic effect is shown.
Table 13 indoor bioactivity assay of carvacrol and menthone compounded Fusarium pseudograminearum
From table 13, it can be seen that carvacrol and menthone after being compounded show excellent antibacterial activity against fusarium pseudograminearum. When the compound proportion of carvacrol and menthone is 8:2, the compound combinations are added to the fusarium pseudograminearum, and the co-toxicity coefficients of the other compound combinations to the fusarium pseudograminearum are all larger than 120, so that the synergistic effect is shown.
Table 14 determination of indoor biological Activity of Fusarium roseum by combination of carvacrol and menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Carvacrol | 27.2423 | 100.0000 | -- | -- |
| Menthone | 110.2090 | 24.7188 | -- | -- |
| Carvacrol 9: menthone 1 | 30.8098 | 88.4209 | 92.4719 | 95.6192 |
| Carvacrol 8: menthone 2 | 51.7604 | 52.6315 | 84.9438 | 61.9605 |
| Carvacrol7: menthone 3 | 44.6211 | 61.0525 | 77.4156 | 78.8633 |
| Carvacrol 6: menthone 4 | 24.6478 | 110.5263 | 69.8875 | 158.1489 |
| Carvacrol 5: menthone 5 | 30.8098 | 88.4209 | 62.3594 | 141.7924 |
| Carvacrol 4: menthone 6 | 76.1183 | 35.7894 | 54.8313 | 65.2719 |
| Carvacrol 3: menthone 7 | 99.5393 | 27.3684 | 47.3031 | 57.8574 |
| Carvacrol 2: menthone 8 | 69.9465 | 38.9473 | 39.7750 | 97.9191 |
| Carvacrol 1: menthone 9 | 57.5116 | 47.3684 | 32.2469 | 146.8928 |
From table 14, it can be seen that carvacrol and menthone show excellent bacteriostatic activity against fusarium erythropolis after being compounded. When the compound proportion of carvacrol and menthone is 6: 4. 5:5 and 1:9, the co-toxicity coefficient of the compound combination on Fusarium rubrum is larger than 120, and the synergistic effect is shown.
Table 15 determination of indoor biological Activity of Fusarium equisetum by complexing carvacrol with menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Carvacrol | 31.9803 | 100.0000 | -- | -- |
| Menthone | 145.5956 | 21.9652 | -- | -- |
| Carvacrol 9: menthone 1 | 31.9803 | 100.0000 | 92.1965 | 108.4640 |
| Carvacrol 8: menthone 2 | 36.1068 | 88.5714 | 84.3930 | 104.9511 |
| Carvacrol 7: menthone 3 | 37.9167 | 84.3436 | 76.5895 | 110.1241 |
| Carvacrol 6: menthone 4 | 44.7724 | 71.4286 | 68.7861 | 103.8417 |
| Carvacrol 5: menthone 5 | 46.8594 | 68.2474 | 60.9826 | 111.9129 |
| Carvacrol 4: menthone 6 | 41.4559 | 77.1429 | 53.1791 | 145.0625 |
| Carvacrol 3: menthone 7 | 37.3103 | 85.7144 | 45.3756 | 188.8997 |
| Carvacrol 2: menthone 8 | 65.8417 | 48.5715 | 37.5721 | 129.2754 |
| Carvacrol 1: menthone 9 | 36.1068 | 88.5714 | 29.7686 | 297.5326 |
From table 15, it can be seen that carvacrol and menthone show excellent antibacterial activity against fusarium equisetum after being compounded. When the compound proportion of carvacrol and menthone is 4-1:6-9, the co-toxicity coefficient of the compound combination on the fusarium equiseti is more than 120, and the synergistic effect is shown.
Table 16 indoor bioactivity assay of Fusarium roseum compounded with carvacrol and menthone
As can be seen from table 16, carvacrol and menthone after being compounded show excellent antibacterial activity against fusarium sp. When the compound proportion of carvacrol and menthone is 5-1:5-1, the compound combination shows additive effect on fusarium; the other compound combinations show synergistic effect on Fusarium layering.
Table 17 determination of indoor biological Activity of Fusarium oxysporum compounded with carvacrol and menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Carvacrol | 29.5089 | 100.0000 | -- | -- |
| Menthone | 144.7977 | 20.3794 | -- | -- |
| Carvacrol 9: menthone 1 | 41.4720 | 71.1538 | 92.0379 | 77.3092 |
| Carvacrol 8: menthone 2 | 43.8418 | 67.3077 | 84.0759 | 80.0559 |
| Carvacrol 7: menthone 3 | 49.4988 | 59.6154 | 76.1138 | 78.3240 |
| Carvacrol 6: menthone 4 | 80.7612 | 36.5385 | 68.1518 | 53.6134 |
| Carvacrol 5: menthone 5 | 85.2479 | 34.6154 | 60.1897 | 57.5105 |
| Carvacrol 4: menthone 6 | 49.4988 | 59.6154 | 52.2276 | 114.1453 |
| Carvacrol 3: menthone 7 | 54.8022 | 53.8462 | 44.2656 | 121.6435 |
| Carvacrol 2: menthone 8 | 76.7231 | 38.4616 | 36.3035 | 105.9444 |
| Carvacrol 1: menthone 9 | 42.1118 | 70.0728 | 28.3415 | 247.2447 |
From table 17, it can be seen that carvacrol and menthone show excellent antibacterial activity against fusarium oxysporum after being compounded. When the compound proportion of carvacrol and menthone is 3:7 and 1:9, the co-toxicity coefficient of the compound combination on fusarium oxysporum is larger than 120, and the synergistic effect is shown.
Table 18 determination of indoor bioactivity of oregano oil and menthone compounded sclerotium rolfsii
From table 18, it can be seen that the aligned micronucleus bacteria showed excellent antibacterial activity after the oregano oil and menthone were compounded. The co-toxicity coefficient of all the tested compound combination aligned sclerotium rolfsii is more than 120, and the synergistic effect is shown.
Table 19 indoor bioactivity assay of origanum oil and menthone compounded Fusarium pseudograminearum
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Oregano oil | 24.2976 | 100.0000 | -- | -- |
| Menthone | 80.5613 | 30.1604 | -- | -- |
| Oregano oil 9: menthone 1 | 16.4613 | 147.6044 | 93.0160 | 158.6870 |
| Oregano oil 8: menthone 2 | 23.1954 | 104.7518 | 86.0321 | 121.7590 |
| Oregano oil 7: menthone 3 | 25.0967 | 96.8159 | 79.0481 | 122.4772 |
| Oregano oil 6: menthone 4 | 21.5619 | 112.6877 | 72.0642 | 156.3713 |
| Oregano oil 5: menthone 5 | 15.4636 | 157.1277 | 65.0802 | 241.4371 |
| Oregano oil 4: menthone 6 | 15.9469 | 152.3657 | 58.0962 | 262.2643 |
| Oregano oil 3: menthone 7 | 30.0176 | 80.9445 | 51.1123 | 158.3661 |
| Oregano oil 2: menthone 8 | 17.2011 | 141.2561 | 44.1283 | 320.1031 |
| Oregano oil 1: menthone 9 | 30.0176 | 80.9445 | 37.1443 | 217.9188 |
From table 19, it can be seen that the oregano oil and menthone after being compounded showed excellent antibacterial activity against fusarium pseudograminearum. The co-toxicity coefficient of all the tested compound combination aligned sclerotium rolfsii is more than 120, and the synergistic effect is shown.
Table 20 indoor biological Activity determination of Rhizoctonia solani in Oregano oil and menthone formulation
From table 20, it can be seen that the Rhizoctonia solani exhibits excellent antibacterial activity after the combination of oregano oil and menthone. When the compounding ratio of the oregano oil and the menthone is 9-4:1-6, the co-toxicity coefficients of the compound combination against rhizoctonia solani are all larger than 120, and the synergistic effect is shown.
Table 21 determination of indoor biological Activity of Fusarium pseudograminearum in combination of Oregano oil and menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Oregano oil | 27.8794 | 100.0000 | -- | -- |
| Menthone | 58.2502 | 47.8615 | -- | -- |
| Oregano oil 9: menthone 1 | 16.9600 | 164.3833 | 94.7861 | 173.4254 |
| Oregano oil 8: menthone 2 | 21.8838 | 127.3974 | 89.5723 | 142.2286 |
| Oregano oil 7: menthone 3 | 26.7789 | 104.1096 | 84.3584 | 123.4134 |
| Oregano oil 6: menthone 4 | 20.7673 | 134.2466 | 79.1446 | 169.6220 |
| Oregano oil 5: menthone 5 | 18.1714 | 153.4246 | 73.9307 | 207.5248 |
| Oregano oil 4: menthone 6 | 18.8444 | 147.9453 | 68.7169 | 215.2969 |
| Oregano oil 3: menthone 7 | 25.4400 | 109.5888 | 63.5030 | 172.5726 |
| Oregano oil 2: menthone 8 | 18.3351 | 152.0548 | 58.2892 | 260.8629 |
| Oregano oil 1: menthone 9 | 27.5027 | 101.3697 | 53.0753 | 190.9921 |
From table 21, it can be seen that the oregano oil and menthone after being compounded showed excellent antibacterial activity against fusarium pseudograminearum. The co-toxicity coefficient of all tested compound combinations to the fusarium pseudograminearum is more than 120, and the synergistic effect is shown.
Table 22 indoor bioactivity assay of Fusarium roseum compounded with oregano oil and menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Oregano oil | 14.7602 | 100.0000 | -- | -- |
| Menthone | 110.2090 | 13.3929 | -- | -- |
| Oregano oil 9: menthone 1 | 10.2933 | 143.3962 | 91.3393 | 156.9929 |
| Oregano oil 8: menthone 2 | 21.7303 | 67.9245 | 82.6786 | 82.1549 |
| Oregano oil 7: menthone 3 | 27.9398 | 52.8286 | 74.0179 | 71.3727 |
| Oregano oil 6: menthone 4 | 41.1732 | 35.8490 | 65.3572 | 54.8510 |
| Oregano oil 5: menthone 5 | 8.5966 | 171.6981 | 56.6965 | 302.8375 |
| Oregano oil 4: menthone 6 | 9.3130 | 158.4903 | 48.0358 | 329.9423 |
| Oregano oil 3: menthone 7 | 78.2291 | 18.8679 | 39.3750 | 47.9185 |
| Oregano oil 2: menthone 8 | 15.9651 | 92.4529 | 30.7143 | 301.0090 |
| Oregano oil 1: menthone 9 | 260.7635 | 5.6604 | 22.0536 | 25.6664 |
From table 22, it can be seen that the oregano oil and menthone showed excellent bacteriostatic activity against fusarium erythropolis after being compounded. When the compounding ratio of the oregano oil and the menthone is 9: 1. 5: 5. 4:6 and 2:8, the co-toxicity coefficient of the compound combination on Fusarium rubrum is larger than 120, and the synergistic effect is shown.
Table 23 indoor biological Activity determination of Fusarium equisetum by Reinforcement of Oregano oil and menthone
From table 23, it can be seen that the oregano oil and menthone after being compounded showed excellent antibacterial activity against fusarium equiseti. When the compounding ratio of the oregano oil and the menthone is 7: and 3, the compound combinations have additive effects on the fusarium equiseti, and the co-toxicity coefficients of the other compound combinations on the fusarium equiseti are all larger than 120, so that the synergistic effect is achieved.
Table 24 indoor bioactivity assay of Fusarium roseum compounded with oregano oil and menthone
| Medicament name and ratio | EC 50 (mg/L) | ATI | TTI | CTC |
| Oregano oil | 30.5120 | 100.0000 | -- | -- |
| Menthone | 114.0774 | 26.7468 | -- | -- |
| Oregano oil 9: menthone 1 | 14.8073 | 206.0605 | 92.6747 | 222.3483 |
| Oregano oil 8: menthone 2 | 29.6146 | 103.0303 | 85.3494 | 120.7159 |
| Oregano oil 7: menthone 3 | 38.7268 | 78.7878 | 78.0240 | 100.9789 |
| Oregano oil 6: menthone 4 | 27.9693 | 109.0910 | 70.6987 | 154.3042 |
| Oregano oil 5: menthone 5 | 15.9825 | 190.9088 | 63.3734 | 301.2445 |
| Oregano oil 4: menthone 6 | 16.2403 | 187.8783 | 56.0481 | 335.2093 |
| Oregano oil 3: menthone 7 | 29.6146 | 103.0303 | 48.7227 | 211.4624 |
| Oregano oil 2: menthone 8 | 12.5862 | 242.4242 | 41.3974 | 585.6026 |
| Oregano oil 1: menthone 9 | 28.7685 | 106.0604 | 34.0721 | 311.2826 |
From table 24, it can be seen that the origanum oil and menthone after being compounded show excellent antibacterial activity against fusarium. When the compounding ratio of the oregano oil and the menthone is 7:3, the compound combination shows additive effect on fusarium; the other compound combinations show synergistic effect on Fusarium layering.
Table 25 determination of indoor biological Activity of Fusarium oxysporum in combination of Oregano oil and menthone
From table 25, it can be seen that the oregano oil and menthone showed excellent bacteriostatic activity against fusarium oxysporum after being compounded. The co-toxicity coefficient of all tested compound combinations to fusarium oxysporum is more than 120, and the synergistic effect is shown. Wherein, when the compounding ratio of the oregano oil and the menthone is 2: and at 8, the co-toxicity coefficient reaches 604.0518, and the synergy is remarkable.
In conclusion, the magnolol, carvacrol or oregano oil and menthone are compounded according to a certain mass, a synergistic effect is shown on pathogenic bacteria of various plant fungal diseases, the control effect on plant diseases can be improved, data support is provided for effective prevention and control of wheat stem basal rot, wheat scab, peanut root rot, peanut southern blight and corn scab, and the method has important significance on high quality and high yield of crops such as wheat, peanut and corn.
The foregoing descriptions of specific exemplary embodiments of the present invention are presented for purposes of illustration and description. It is not intended to limit the invention to the precise form disclosed, and obviously many modifications and variations are possible in light of the above teaching. The exemplary embodiments were chosen and described in order to explain the specific principles of the invention and its practical application to thereby enable one skilled in the art to make and utilize the invention in various exemplary embodiments and with various modifications as are suited to the particular use contemplated. It is intended that the scope of the invention be defined by the claims and their equivalents.
Claims (6)
1. The sterilizing composition containing menthone is characterized in that the effective components of the sterilizing composition are compounded by magnolol, carvacrol or oregano oil and menthone.
2. The menthone-containing bactericidal composition according to claim 1, wherein the mass ratio of magnolol to menthone is 1-9:9-1.
3. The menthone-containing bactericidal composition according to claim 1, wherein the mass ratio of carvacrol to menthone is 1-9:9-1.
4. The menthone-containing bactericidal composition according to claim 1, wherein the mass ratio of oregano oil to menthone is 1-9:9-1.
5. Use of a bactericidal composition containing menthone according to any of claims 1-4 for controlling fungal diseases of crops.
6. The use according to claim 5, wherein the crop fungal diseases include wheat stem rot, wheat scab, peanut root rot, peanut southern blight and corn scab.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311019812.6A CN117223710A (en) | 2023-08-14 | 2023-08-14 | Sterilizing composition containing menthone |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202311019812.6A CN117223710A (en) | 2023-08-14 | 2023-08-14 | Sterilizing composition containing menthone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN117223710A true CN117223710A (en) | 2023-12-15 |
Family
ID=89091985
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202311019812.6A Pending CN117223710A (en) | 2023-08-14 | 2023-08-14 | Sterilizing composition containing menthone |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN117223710A (en) |
-
2023
- 2023-08-14 CN CN202311019812.6A patent/CN117223710A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN113661998B (en) | Energy metabolism repressor for resisting gray mold | |
| CN114794129A (en) | Bactericide for anti-anthracnose breeding | |
| CN110169422B (en) | Compound formulation plant bactericide and preparation method and application thereof | |
| CN117223710A (en) | Sterilizing composition containing menthone | |
| CN116965409A (en) | Pesticide composition containing menthone | |
| CN104705324A (en) | Sterilizing composition containing zhongshengmycin and chitosan oligosaccharide | |
| CN114651825A (en) | Macadimia nut stem canker inhibitor based on molecular disease resistance approach | |
| CN113994972B (en) | Composition for treating gummosis of nectarines | |
| CN117084246A (en) | Sterilization composition containing resveratrol | |
| CN116019116B (en) | Pesticide powder and application method thereof | |
| CN113207898B (en) | Bactericide composition for preventing and treating wheat scab | |
| CN117084245A (en) | Pesticide composition containing resveratrol | |
| CN115968880B (en) | Sterilization composition for preventing and treating wheat powdery mildew | |
| CN109907051B (en) | Insecticidal composition containing fluazinam and propargite | |
| CN117099780A (en) | Bactericidal composition containing aloe-emodin | |
| CN117099781A (en) | Synergistic composition containing aloe-emodin | |
| CN116267957A (en) | Biopesticide for preventing and treating pineapple heart rot | |
| CN116965417A (en) | Synergistic bactericidal composition containing triclocarban | |
| CN116784345A (en) | Composition for improving nitrogen absorption of wheat plants | |
| CN116172012A (en) | Sterilization composition for preventing and treating powdery mildew of bitter gourd | |
| CN117958278A (en) | Pesticide preparation for preventing and treating powdery mildew of macadimia nut | |
| CN116965416A (en) | Combined sterilization composition containing triclocarban | |
| CN114304168A (en) | Bactericidal composition containing benziothiazolinone and isoprothiolane and application thereof | |
| CN114766513A (en) | Silver ion antibacterial liquid containing coumarin-3-carboxylic acid and preparation method and application thereof | |
| CN117044723A (en) | Synergistic composition for preventing and treating mango anthracnose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |